Contrast media triggering cutaneous graft-versus-host disease

被引:4
作者
Vavricka, SR
Halter, J
Furrer, K
Wolfensberger, U
Schanz, U
机构
[1] Univ Zurich Hosp, Dept Med, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Dept Radiol, CH-8091 Zurich, Switzerland
关键词
bone marrow transplantation; graft-versus-host disease; contrast media;
D O I
10.1038/sj.bmt.1703564
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Adverse reactions to iodinated contrast media are varied and known to develop in patients with asthma and a history of allergy. We describe three successful allogeneic bone marrow transplantation (BMT) patients, who all developed dermal graft-versus-host disease (GVHD) after receiving contrast media. Cutaneous GVHD triggered by contrast media has not been reported to date and has implications for the assessment, monitoring and treatment of patients during the post-transplant period.
引用
收藏
页码:899 / 901
页数:3
相关论文
共 14 条
[1]  
ALMEN T, 1994, INVEST RADIOL, V29, pS37
[2]  
BACIGALUPO A, 1990, BONE MARROW TRANSPL, V6, P341
[3]  
Barbaud A, 1997, EUR J DERMATOL, V7, P319
[4]  
BOLGER GB, 1986, BONE MARROW TRANSPL, V1, P21
[5]   A EUROPEAN MULTICENTER STUDY OF CHRONIC GRAFT-VERSUS-HOST DISEASE - THE ROLE OF CYTOMEGALOVIRUS SEROLOGY IN RECIPIENTS AND DONORS - ACUTE GRAFT-VERSUS-HOST DISEASE, AND SPLENECTOMY [J].
BOSTROM, L ;
RINGDEN, O ;
JACOBSEN, N ;
ZWAAN, F ;
NILSSON, B .
TRANSPLANTATION, 1990, 49 (06) :1100-1105
[6]   Delayed allergy-like reactions to X-ray contrast media: mechanistic considerations [J].
Christiansen, C ;
Pichler, WJ ;
Skotland, T .
EUROPEAN RADIOLOGY, 2000, 10 (12) :1965-1975
[7]  
DEGAST GC, 1991, BONE MARROW TRANSPL, V7, P293
[8]   AUGMENTATION OF GRAFT-VERSUS-HOST REACTION BY CYTOMEGALO-VIRUS INFECTION RESULTING IN INTERSTITIAL PNEUMONITIS [J].
GRUNDY, JE ;
SHANLEY, JD ;
SHEARER, GM .
TRANSPLANTATION, 1985, 39 (05) :548-553
[9]   LONG-TERM CYCLOSPORINE THERAPY MAY DECREASE THE RISK OF CHRONIC GRAFT-VERSUS-HOST DISEASE [J].
LONNQVIST, B ;
ASCHAN, J ;
LJUNGMAN, P ;
RINGDEN, O .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 74 (04) :547-548
[10]   Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease [J].
Przepiorka, D ;
Kernan, NA ;
Ippoliti, C ;
Papadopoulos, EB ;
Giralt, S ;
Khouri, I ;
Lu, JG ;
Gajewski, J ;
Durett, A ;
Cleary, K ;
Champlin, R ;
Andersson, BS ;
Light, S .
BLOOD, 2000, 95 (01) :83-89